Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.

Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR; MGTX Study Group.

Lancet Neurol. 2019 Mar;18(3):259-268. doi: 10.1016/S1474-4422(18)30392-2. Epub 2019 Jan 25.

PMID:
30692052
2.

Lawful physician-hastened death: AAN position statement.

Russell JA, Epstein LG, Bonnie RJ, Conwit R, Graf WD, Kirschen M, Kurek JA, Larriviere DG, Pascuzzi RM, Rizzo M, Sattin JA, Simmons Z, Taylor L, Tsou A, Williams MA; Ethics, Law, and Humanities Committee (a joint committee of the AAN, ANA, and CNS); Ethics, Law and Humanities Committee, a joint committee of the AAN, ANA and CNS.

Neurology. 2018 Feb 27;90(9):420-422. doi: 10.1212/WNL.0000000000005012. No abstract available.

3.

Reply.

Sanders DB, Harati Y, Juel VC, Lou JS, Marburger T, Pascuzzi RM, Peltier AC, Richman DP, Smith AG.

Muscle Nerve. 2018 May;57(5):E130-E131. doi: 10.1002/mus.26089. Epub 2018 Mar 1. No abstract available.

PMID:
29406616
4.

3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.

Sanders DB, Juel VC, Harati Y, Smith AG, Peltier AC, Marburger T, Lou JS, Pascuzzi RM, Richman DP, Xie T, Demmel V, Jacobus LR, Aleš KL, Jacobus DP; Dapper Study Team.

Muscle Nerve. 2018 Apr;57(4):561-568. doi: 10.1002/mus.26052. Epub 2018 Feb 2.

5.

Randomized Trial of Thymectomy in Myasthenia Gravis.

Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR; MGTX Study Group.

N Engl J Med. 2016 Aug 11;375(6):511-22. doi: 10.1056/NEJMoa1602489. Erratum in: N Engl J Med. 2017 May 25;376(21):2097. [Dosage error in article text].

6.

Corrigendum: Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.

Fontanilla CV, Gu H, Liu Q, Zhu TZ, Zhou C, Johnstone BH, March KL, Pascuzzi RM, Farlow MR, Du Y.

Sci Rep. 2016 Apr 15;6:20747. doi: 10.1038/srep20747. No abstract available.

7.

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.

Burns TM, Smith GA, Allen JA, Amato AA, Arnold WD, Barohn R, Benatar M, Bird SJ, Bromberg M, Chahin N, Ciafaloni E, Cohen JA, Corse A, Crum BA, David WS, Dimberg E, Sousa EA, Donofrio PD, Dyck PJ, Engel AG, Ensrud ER, Ferrante M, Freimer M, Gable KL, Gibson S, Gilchrist JM, Goldstein JM, Gooch CL, Goodman BP, Gorelov D, Gospe SM Jr, Goyal NA, Guidon AC, Guptill JT, Gutmann L, Gutmann L, Gwathmey K, Harati Y, Harper CM Jr, Hehir MK, Hobson-Webb LD, Howard JF Jr, Jackson CE, Johnson N, Jones SM, Juel VC, Kaminski HJ, Karam C, Kennelly KD, Khella S, Khoury J, Kincaid JC, Kissel JT, Kolb N, Lacomis D, Ladha S, Larriviere D, Lewis RA, Li Y, Litchy WJ, Logigian E, Lou JS, MacGowen DJ, Maselli R, Massey JM, Mauermann ML, Mathews KD, Meriggioli MN, Miller RG, Moon JS, Mozaffar T, Nations SP, Nowak RJ, Ostrow LW, Pascuzzi RM, Peltier A, Ruzhansky K, Richman DP, Ross MA, Rubin DI, Russell JA, Sachs GM, Salajegheh MK, Saperstein DS, Scelsa S, Selcen D, Shaibani A, Shieh PB, Silvestri NJ, Singleton JR, Smith BE, So YT, Solorzano G, Sorenson EJ, Srinivasen J, Tavee J, Tawil R, Thaisetthawatkul P, Thornton C, Trivedi J, Vernino S, Wang AK, Webb TA, Weiss MD, Windebank AJ, Wolfe GI.

Muscle Nerve. 2016 Feb;53(2):165-8. doi: 10.1002/mus.25009. Epub 2015 Dec 21. No abstract available.

PMID:
26662952
8.

Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.

Fontanilla CV, Gu H, Liu Q, Zhu TZ, Zhou C, Johnstone BH, March KL, Pascuzzi RM, Farlow MR, Du Y.

Sci Rep. 2015 Nov 20;5:16953. doi: 10.1038/srep16953. Erratum in: Sci Rep. 2016;6:20747.

9.

Reply: Can we say that modern radiologic contrast agents are safe in myasthenia gravis?

Mehrizi M, Pascuzzi RM.

Muscle Nerve. 2015 May;51(5):783. doi: 10.1002/mus.24591. Epub 2015 Mar 14. No abstract available.

PMID:
25656615
10.

A genome-wide association study of myasthenia gravis.

Renton AE, Pliner HA, Provenzano C, Evoli A, Ricciardi R, Nalls MA, Marangi G, Abramzon Y, Arepalli S, Chong S, Hernandez DG, Johnson JO, Bartoccioni E, Scuderi F, Maestri M, Gibbs JR, Errichiello E, Chiò A, Restagno G, Sabatelli M, Macek M, Scholz SW, Corse A, Chaudhry V, Benatar M, Barohn RJ, McVey A, Pasnoor M, Dimachkie MM, Rowin J, Kissel J, Freimer M, Kaminski HJ, Sanders DB, Lipscomb B, Massey JM, Chopra M, Howard JF Jr, Koopman WJ, Nicolle MW, Pascuzzi RM, Pestronk A, Wulf C, Florence J, Blackmore D, Soloway A, Siddiqi Z, Muppidi S, Wolfe G, Richman D, Mezei MM, Jiwa T, Oger J, Drachman DB, Traynor BJ.

JAMA Neurol. 2015 Apr;72(4):396-404. doi: 10.1001/jamaneurol.2014.4103.

11.

Complications of radiologic contrast in patients with myasthenia gravis.

Mehrizi M, Pascuzzi RM.

Muscle Nerve. 2014 Sep;50(3):443-4. doi: 10.1002/mus.24254. Epub 2014 Aug 5.

PMID:
24677227
12.

Association between performance on Neurology In-Training and Certification Examinations.

Juul D, Flynn FG, Gutmann L, Pascuzzi RM, Webb L, Massey JM, Dekosky ST, Foertsch M, Faulkner LR.

Neurology. 2013 Jan 8;80(2):206-9. doi: 10.1212/WNL.0b013e31827b92a3.

13.

Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.

Fontanilla CV, Wei X, Zhao L, Johnstone B, Pascuzzi RM, Farlow MR, Du Y.

Neuroscience. 2012 Mar 15;205:185-93. doi: 10.1016/j.neuroscience.2011.12.025. Epub 2011 Dec 24.

PMID:
22206942
14.

Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population.

Bhakta D, Shen C, Kron J, Epstein AE, Pascuzzi RM, Groh WJ.

J Cardiovasc Electrophysiol. 2011 Dec;22(12):1369-75. doi: 10.1111/j.1540-8167.2011.02200.x. Epub 2011 Oct 28.

PMID:
22035077
15.

Survival and CTG repeat expansion in adults with myotonic dystrophy type 1.

Groh WJ, Groh MR, Shen C, Monckton DG, Bodkin CL, Pascuzzi RM.

Muscle Nerve. 2011 May;43(5):648-51. doi: 10.1002/mus.21934.

PMID:
21484823
16.

Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1.

Bhakta D, Groh MR, Shen C, Pascuzzi RM, Groh WJ.

Am Heart J. 2010 Dec;160(6):1137-41, 1141.e1. doi: 10.1016/j.ahj.2010.07.032.

PMID:
21146669
17.

Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties.

Faulkner LR, Juul D, Pascuzzi RM, Aminoff MJ, Crumrine PK, Dekosky ST, Jozefowicz RF, Massey JM, Pirzada N, Tilton A.

Neurology. 2010 Sep 21;75(12):1110-7. doi: 10.1212/WNL.0b013e3181f39a41.

18.

Shostakovich and ALS.

Kalapatapu VR, Gilkey AP, Pascuzzi RM.

Front Neurol Neurosci. 2010;27:92-100. doi: 10.1159/000311194. Epub 2010 Apr 6.

PMID:
20375524
19.

A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis.

Pascuzzi RM, Shefner J, Chappell AS, Bjerke JS, Tamura R, Chaudhry V, Clawson L, Haas L, Rothstein JD.

Amyotroph Lateral Scler. 2010 May 3;11(3):266-71. doi: 10.3109/17482960903307805.

PMID:
19961264
20.

A dinosaur roars: assessing clinical skills in residency.

Pascuzzi RM.

Neurology. 2009 Sep 15;73(11):826-7. doi: 10.1212/WNL.0b013e3181b72640. Epub 2009 Aug 26. No abstract available.

PMID:
19710405
21.

Arrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1.

Otten RF, Scherschel JA, Lopshire JC, Bhakta D, Pascuzzi RM, Groh WJ.

Muscle Nerve. 2009 Nov;40(5):901-2. doi: 10.1002/mus.21345. No abstract available.

PMID:
19623641
22.

Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review.

Nelson RP Jr, Pascuzzi RM, Kessler K, Walsh LE, Faught PP, Ramanuja S, Pescovitz MD, Loehrer PJ Sr.

J Clin Neuromuscul Dis. 2009 Jun;10(4):170-7. doi: 10.1097/CND.0b013e31819a8403. Review.

PMID:
19494727
23.

Peripheral neuropathy.

Pascuzzi RM.

Med Clin North Am. 2009 Mar;93(2):317-42, vii-viii. doi: 10.1016/j.mcna.2008.12.001. Review.

PMID:
19272511
24.

Paraneoplastic syndromes in thymoma: an immunological perspective.

Nelson RP Jr, Pascuzzi RM.

Curr Treat Options Oncol. 2008 Dec;9(4-6):269-76. doi: 10.1007/s11864-008-0081-1. Epub 2009 Feb 6.

PMID:
19199040
25.

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.

Sorenson EJ, Windbank AJ, Mandrekar JN, Bamlet WR, Appel SH, Armon C, Barkhaus PE, Bosch P, Boylan K, David WS, Feldman E, Glass J, Gutmann L, Katz J, King W, Luciano CA, McCluskey LF, Nash S, Newman DS, Pascuzzi RM, Pioro E, Sams LJ, Scelsa S, Simpson EP, Subramony SH, Tiryaki E, Thornton CA.

Neurology. 2008 Nov 25;71(22):1770-5. doi: 10.1212/01.wnl.0000335970.78664.36.

26.

Invited article: The ABPN maintenance of certification program for neurologists: past, present, and future.

Faulkner LR, Tivnan PW, Johnston MV, Aminoff MJ, Coyle PK, Crumrine PK, Dekosky ST, Jozefowicz R, Massey JM, Pascuzzi RM.

Neurology. 2008 Aug 19;71(8):599-604. doi: 10.1212/01.wnl.0000310815.29495.85. Epub 2008 Jul 2. No abstract available.

PMID:
18596242
27.

Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.

Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM.

N Engl J Med. 2008 Jun 19;358(25):2688-97. doi: 10.1056/NEJMoa062800.

28.

Thymoma, myasthenia gravis, and other paraneoplastic syndromes.

Tormoehlen LM, Pascuzzi RM.

Hematol Oncol Clin North Am. 2008 Jun;22(3):509-26. doi: 10.1016/j.hoc.2008.03.004. Review.

PMID:
18514130
29.

Opinion/education: the ABPN is the neurology resident's best friend.

Pascuzzi RM.

Neurology. 2008 Jan 29;70(5):e16-9. doi: 10.1212/01.wnl.0000297220.42127.6b. No abstract available.

PMID:
18227411
30.

Expectant management of deep cerebral venous thrombosis with intraventricular hemorrhage.

Meschia JF, Pascuzzi RM, Biller J.

J Stroke Cerebrovasc Dis. 1997 Oct-Nov;6(6):434-5.

PMID:
17895048
31.

Neuromuscular disorders in clinical practice: case studies.

Bhatt JR, Pascuzzi RM.

Neurol Clin. 2006 May;24(2):233-65.

PMID:
16684631
32.

Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1.

Groh WJ, Lowe MR, Simmons Z, Bhakta D, Pascuzzi RM.

Muscle Nerve. 2005 Jun;31(6):719-24.

PMID:
15770673
33.

A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.

Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr, Johnson H, Qureshi M, Jacobs M, Rothstein JD, Appel SH, Pascuzzi RM, Heiman-Patterson TD, Donofrio PD, David WS, Russell JA, Tandan R, Pioro EP, Felice KJ, Rosenfeld J, Mandler RN, Sachs GM, Bradley WG, Raynor EM, Baquis GD, Belsh JM, Novella S, Goldstein J, Hulihan J; Northeast ALS Consortium.

Neurology. 2003 Aug 26;61(4):456-64.

PMID:
12939417
34.

The edrophonium test.

Pascuzzi RM.

Semin Neurol. 2003 Mar;23(1):83-8. Review.

PMID:
12870109
35.

Peripheral neuropathies in clinical practice.

Pascuzzi RM.

Med Clin North Am. 2003 May;87(3):697-724. Review.

PMID:
12812409
36.
37.

Myasthenia gravis and Lambert-Eaton syndrome.

Pascuzzi RM.

Ther Apher. 2002 Feb;6(1):57-68. Review.

PMID:
11886578
38.

Pearls and pitfalls in the diagnosis and management of neuromuscular junction disorders.

Pascuzzi RM.

Semin Neurol. 2001 Dec;21(4):425-40. Review.

PMID:
11774058
39.

Neurology in the art museum: Andrew Wyeth's Christina's World.

Pascuzzi RM, Brooks JO.

Semin Neurol. 2000;20(2):255-9.

PMID:
10946746
40.

Hors d'oeuvres for neurology.

Pascuzzi RM.

Semin Neurol. 1999;19(2):235-7.

PMID:
10718544
41.

Shostakovich and amyotrophic lateral sclerosis.

Pascuzzi RM.

Semin Neurol. 1999;19 Suppl 1:63-6.

PMID:
10718531
42.

Ravel's neurological illness.

Alonso RJ, Pascuzzi RM.

Semin Neurol. 1999;19 Suppl 1:53-7.

PMID:
10718529
43.

Early observations on muscular dystrophy: Gowers' textbook revisited.

Pascuzzi RM.

Semin Neurol. 1999;19(1):87-92.

PMID:
10711992
44.
45.
46.

Drugs and toxins associated with myopathies.

Pascuzzi RM.

Curr Opin Rheumatol. 1998 Nov;10(6):511-20. Review.

PMID:
9812211
47.

Pearls and pitfalls in the horror cinema.

Pascuzzi RM.

Semin Neurol. 1998;18(2):267-73.

PMID:
9608623
48.

Primary intravascular lymphomatosis associated with Mycobacterium marinum.

Sokol DK, Azzarelli B, Smith RR, Kassing LC, Roos KL, Pascuzzi RM, Blinkhorn RJ Jr.

J Neuroimaging. 1998 Jan;8(1):47-9.

PMID:
9442593
49.

Controlled clinical trials of anything in myasthenia gravis.

Pascuzzi RM.

Arch Neurol. 1997 Nov;54(11):1323. No abstract available.

PMID:
9362974
50.

Acute peripheral neuropathy in adults. Guillain-Barré syndrome and related disorders.

Pascuzzi RM, Fleck JD.

Neurol Clin. 1997 Aug;15(3):529-47. Review.

PMID:
9227951

Supplemental Content

Loading ...
Support Center